News Sentiment

600572 sentiment intelligence

Zhejiang CONBA Pharmaceutical Co.,Ltd. news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.

Chart Weekly report RSS feed
Weighted score 50 Balanced news tone 1 relevant articles
Exchange SHH China
Sector Healthcare Market context
Industry Drug Manufacturers - Specialty & Generic Read-through group
Latest close 4.28 Week of 17 Jul 2026
Weighted tone 50/100

Balanced news tone

Market reaction Balanced read

News tone and price action are not far from neutral.

Primary event Market update

72/100 classification confidence.

Company focus 1

directly relevant article

Source quality 0

high-authority source matches

Trend context Trend inactive

+3.9% over one week, +7.7% over four weeks, trend inactive, and near fair-value range.

Latest direct headline Neutral

Adneuris Therapeutics Grants Exclusive License to Zhejiang Conba Pharmaceutical to Advance Cebranopadol in Greater China

Market Reaction

Balanced read

55/100 confidence

News tone and price action are not far from neutral.

Primary event Market update 72/100 classification
One-week reaction 3.9% Price confirming higher
Trend fit Trend inactive 7.7% over four weeks
Fair value -5.0% Near fair-value range

Sentiment Mix

Positive, neutral, negative

Weighted by relevance
Positive 0
Neutral 1
Negative 0

Relevance

Why the article matched

Direct first
Direct company coverage 1
Industry context 0
Sector context 0

Sources

Coverage mix

Publishers
The Manila Times 1

Event Lens

What the news is about

Classified themes
Market update 1

Sentiment Trail

Score over time

50 baseline
Above 50 Neutral zone Below 50

News Tape

Relevant headlines

Showing 1-1 of 1